Trial Design Solutions
-
Central Nervous System Drug Development
1/16/2026
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
-
The Asia Drug Development Advantage
8/8/2024
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
-
TrialScope Disclose
6/13/2022
With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
-
Eliminate Review Friction With An Industry-First IRB Platform
3/5/2026
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
-
Informed Diversity Action Planning Made Simple
11/26/2024
Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.
-
Metabolic Disorders
10/8/2024
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
Ethnobridging: Clinical Research Capabilities
1/26/2023
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
A New Blueprint For Transforming Feasibility And Recruitment
10/20/2025
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
Your Top Partner For Ophthalmic Drug Development
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Engaging, Empowering & Supporting Research Sites Around The World
3/19/2025
Accelerate trial timelines and recruitment while reducing site burden through this site network solution.